|
|
 | NEWS |
|
| June 27, 2006
• New Perspectives in GMP Biomanufacturing, the Genopole® symposium
| Genopole® is organizing a colloquium dedicated to biomanufacturing in Evry on October 24th, 2006. For the event's first edition, France's leading biocluster has decided to link up with EuroBio 2006 (the 10th European Biotech Crossroads).
The goal of this international symposium is to bring together the world's leading experts (from academy, life science companies and industrial businesses) in the field of biomanufacturing. It will provide a snapshot of the main innovations in biological drug production and regulatory issues, as well as a focus on the development and optimization of a protein's activity.
In fact, Genopole® is set to become one of France's top biomanufacturing locations - notably via the forthcoming opening (in September 2007) of an industrial GMP biomanufacturing centre at the heart of the Evry biopark, in collaboration with the MAbgène company.
In view of the difficulties faced by biotech companies in producing their lead molecules in France (where supply is weak), the center will offer life science businesses, pharma companies and academic labs access to preclinical and Phase I & II clinical batches with competitive pricing and short lead-in times. Initially, the Genopole® biomanufacturing center will custom-produce biological drugs (recombinant proteins and monoclonal antibodies) in animal cells. In the mid-term, it will offer other active compounds for use in fine chemicals and the industrial, value-added exploitation of agricultural resources. | |
|
|
Last update:
0-, 2006
